Hongbo Wang

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Endometrial Cancer

Signaling Pathway

Mesenchymal Stem Cells

Magnetic Resonance

Top Venues

Cancer gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Rui Shi, Rong Zhao, Yan Shen, Sitian Wei, Tangansu Zhang, Jun Zhang, Wan Shu, Shuangshuang Cheng, Hua Teng, Hongbo Wang
IGF2BP2-modified circular RNA circCHD7 promotes endometrial cancer progression via stabilizing PDGFRB and activating JAK/STAT signaling pathway. Cancer gene therapy (2024)
Rui Shi, Rong Zhao, Yan Shen, Sitian Wei, Tangansu Zhang, Jun Zhang, Wan Shu, Shuangshuang Cheng, Hua Teng, Hongbo Wang
IGF2BP2-modified circular RNA circCHD7 promotes endometrial cancer progression via stabilizing PDGFRB and activating JAK/STAT signaling pathway. Cancer gene therapy 31 (8) (2024)
Qi Zhang, Yuwei Yao, Zhicheng Yu, Ting Zhou, Qian Zhang, Haojia Li, Jun Zhang, Sitian Wei, Tangansu Zhang, Hongbo Wang
Bioinformatics Analysis and Experimental Verification Define Different Angiogenesis Subtypes in Endometrial Carcinoma and Identify a Prognostic Signature. ACS omega 9 (24) (2024)
Qi Zhang, Yuwei Yao, Zhicheng Yu, Ting Zhou, Qian Zhang, Haojia Li, Jun Zhang, Sitian Wei, Tangansu Zhang, Hongbo Wang
Bioinformatics Analysis and Experimental Verification Define Different Angiogenesis Subtypes in Endometrial Carcinoma and Identify a Prognostic Signature. ACS omega 9 (24) (2024)
Rui Shi, Rong Zhao, Yan Shen, Sitian Wei, Tangansu Zhang, Jun Zhang, Wan Shu, Shuangshuang Cheng, Hua Teng, Hongbo Wang
IGF2BP2-modified circular RNA circCHD7 promotes endometrial cancer progression via stabilizing PDGFRB and activating JAK/STAT signaling pathway. Cancer gene therapy 31 (8) (2024)
Rui Shi, Rong Zhao, Yan Shen, Sitian Wei, Tangansu Zhang, Jun Zhang, Wan Shu, Shuangshuang Cheng, Hua Teng, Hongbo Wang
IGF2BP2-modified circular RNA circCHD7 promotes endometrial cancer progression via stabilizing PDGFRB and activating JAK/STAT signaling pathway. Cancer gene therapy 31 (8) (2024)